IJR News — today's news from every sideMarcus Bell Hope this means more hiring soon as the jump in two months looks like real recovery. Dana Whitfield This loss of 13 million books will set Ukrainian publishing back for years. Maya Lindstrom Leaving the car against police orders during a DUI stop was a dumb move no matter who was driving. Rachel Meyers An engineer breaking down the dry ground formation adds practical detail that makes the event feel less like pure legend. Dr. David Crean Book Guides Biopharma Leaders on Commercialization — Sep 18, 2026A new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC.
Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.Derek Foss Rushdie deserves this for his fearless writing that has connected so many readers across borders over decades. Tom Gallagher Boeing's 2027 delivery target feels optimistic when ETOPS testing is stalled over a basic engine part issue. Chris Dalton hours sounds great on paper but real world use always cuts that down by a third at least, still impressive if true. Chris Dalton The 2023 study missed the refundable credit which could cut upfront costs a lot if they rerun the numbers.